CHANGING VIRUS-HOST INTERACTIONS IN THE COURSE OF HIV-1 INFECTION

被引：145

作者：

MIEDEMA, F

MEYAARD, L

KOOT, M

KLEIN, MR

ROOS, MTL

GROENINK, M

FOUCHIER, RAM

VANTWOUT, AB

TERSMETTE, M

SCHELLEKENS, PTA

SCHUITEMAKER, H

机构：

[1] Department of Clinical Viro-immunology, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Laboratory of Experimental and Clinical Immunology, University of Amsterdam, Amsterdam

来源：

IMMUNOLOGICAL REVIEWS | 1994年 / 140卷

关键词：

D O I：

10.1111/j.1600-065X.1994.tb00864.x

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：35 / 72

页数：38

共 198 条

[81] LYMPHOCYTE-T T4 MOLECULE BEHAVES AS THE RECEPTOR FOR HUMAN RETROVIRUS LAV [J].

KLATZMANN, D ;

CHAMPAGNE, E ;

CHAMARET, S ;

GRUEST, J ;

GUETARD, D ;

HERCEND, T ;

GLUCKMAN, JC ;

MONTAGNIER, L .

NATURE, 1984, 312 (5996) :767-768

[82] DETECTION OF AIDS VIRUS IN MACROPHAGES IN BRAIN-TISSUE FROM AIDS PATIENTS WITH ENCEPHALOPATHY [J].

KOENIG, S ;

GENDELMAN, HE ;

ORENSTEIN, JM ;

DALCANTO, MC ;

PEZESHKPOUR, GH ;

YUNGBLUTH, M ;

JANOTTA, F ;

AKSAMIT, A ;

MARTIN, MA ;

FAUCI, AS .

SCIENCE, 1986, 233 (4768) :1089-1093

[83] PROGNOSTIC VALUE OF HIV-1 SYNCYTIUM-INDUCING PHENOTYPE FOR RATE OF CD4+ CELL DEPLETION AND PROGRESSION TO AIDS [J].

KOOT, M ;

KEET, IPM ;

VOS, AHV ;

DEGOEDE, REY ;

ROOS, MTL ;

COUTINHO, RA ;

MIEDEMA, F ;

SCHELLEKENS, PTA ;

TERSMETTE, M .

ANNALS OF INTERNAL MEDICINE, 1993, 118 (09) :681-688

[84] HIV-1 BIOLOGICAL PHENOTYPE IN LONG-TERM INFECTED INDIVIDUALS EVALUATED WITH AN MT-2 COCULTIVATION ASSAY [J].

KOOT, M ;

VOS, AHV ;

KEET, RPM ;

DEGOEDE, REY ;

DERCKSEN, MW ;

TERPSTRA, FG ;

COUTINHO, RA ;

MIEDEMA, F ;

TERSMETTE, M .

AIDS, 1992, 6 (01) :49-54

[85] VIRAL PHENOTYPE AND T-CELL REACTIVITY IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED ASYMPTOMATIC MEN TREATED WITH ZIDOVUDINE [J].

KOOT, M ;

SCHELLEKENS, PTA ;

MULDER, JW ;

LANGE, JMA ;

ROOS, MTL ;

COUTINHO, RA ;

TERSMETTE, M ;

MIEDEMA, F .

JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (03) :733-736

[86] EVOLUTION OF THE V3 ENVELOPE DOMAIN IN PROVIRAL SEQUENCES AND ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DURING TRANSITION OF THE VIRAL BIOLOGICAL PHENOTYPE [J].

KUIKEN, CL ;

DEJONG, JJ ;

BAAN, E ;

KEULEN, W ;

TERSMETTE, M ;

GOUDSMIT, J .

JOURNAL OF VIROLOGY, 1992, 66 (07) :4622-4627

[87] LYSIS OF INFECTED-CELLS IN-VIVO BY ANTIVIRAL CYTOLYTIC T-CELLS DEMONSTRATED BY RELEASE OF CELL INTERNAL VIRAL-PROTEINS [J].

KYBURZ, D ;

SPEISER, DE ;

BATTEGAY, M ;

HENGARTNER, H ;

ZINKERNAGEL, RM .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (07) :1540-1545

[88] ABNORMALITIES OF B-CELL ACTIVATION AND IMMUNOREGULATION IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].

LANE, HC ;

MASUR, H ;

EDGAR, LC ;

WHALEN, G ;

ROOK, AH ;

FAUCI, AS .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (08) :453-458

[89] QUALITATIVE-ANALYSIS OF IMMUNE FUNCTION IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME - EVIDENCE FOR A SELECTIVE DEFECT IN SOLUBLE-ANTIGEN RECOGNITION [J].

LANE, HC ;

DEPPER, JM ;

GREENE, WC ;

WHALEN, G ;

WALDMANN, TA ;

FAUCI, AS .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (02) :79-84

[90] MARKERS FOR PROGRESSION IN HIV INFECTION [J].

LANGE, JMA ;

DEWOLF, F ;

GOUDSMIT, J .

AIDS, 1989, 3 :S153-S160

← 4 5 6 7 8 9 10 11 12 13 →